Senzime AB
Research Senzime AB (SEZI) on Bullrun: market cap SEK 676.02M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSEZI
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Devices
- CurrencySEK
- Market capSEK 676.02M
- Financial periodFY2024
- RevenueSEK 58.48M
- Revenue growth63.6%
- Net income-SEK 118.73M
- Free cash flow-SEK 108.30M
- Gross margin34.4%
Valuation Snapshot
latest market cap is SEK 676.02M.
About Senzime AB
Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. The company offers TetraGraph, quantitative train of-four (TOF) monitoring refined by real-world patient data; and ExSpiron, a non-invasive monitoring system that uses bioelectrical impedance sensor to measure the tissue's opposition to carrying an alternating electrical current.
Frequently asked questions
What is Senzime AB's market cap?
Senzime AB's market capitalization is SEK 676.02M.
What does Senzime AB do?
Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States.